Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (40,028)	$ (39,209)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,808	5,618
Stock-based compensation expense	1,638	2,508
Inventory impairments and option contract abandonments	2,246	4,707
Deferred and other income tax benefit	(577)	(36,278)
Provision for doubtful accounts	(184)	227
Equity in (income) loss of unconsolidated entities	(104)	109
Cash distributions of income from unconsolidated entities	336	0
Loss on extinguishment of debt	1,517	2,747
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(287)	6,375
Decrease in income tax receivable	3,859	2,424
Increase in inventory	(40,407)	(14)
Decrease in other assets	2,823	7,420
Decrease in trade accounts payable	(7,033)	(17,748)
Decrease in other liabilities	(6,050)	(18,905)
Other changes	107	(7)
Net cash used in operating activities	(76,336)	(80,026)
Cash flows from investing activities:
Capital expenditures	(3,869)	(12,488)
Investments in unconsolidated entities	(400)	(810)
Return of capital from unconsolidated entities	(432)	(428)
Increases in restricted cash	(1,044)	(888)
Decreases in restricted cash	7,562	551
Net cash provided by (used in) investing activities	2,681	(13,207)
Cash flows from financing activities:
Repayment of debt	(183,319)	(2,899)
Proceeds from issuance of new debt	200,000	0
Debt issuance costs	(4,635)	(97)
Equity issuance costs	0	(1,212)
Settlement of unconsolidated entity debt obligation	(500)	(15,862)
Payments for other financing activities	(26)	(72)
Net cash provided by (used in) financing activities	11,520	(20,142)
Decrease in cash and cash equivalents	(62,135)	(113,375)
Cash and cash equivalents at beginning of period	487,795	370,403
Cash and cash equivalents at end of period	$ 425,660	$ 257,028